Search Results 931-940 of 13825 for Assay

1. Liver Tumors Clinical Trials - Mayo Clinic Research

   GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

2. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

   - Serum FLC assay: Involved FLC level ≥ 10 mg/dL provided serum FLC ratio is abnormal. [CLOSED] Patients with Chronic Lymphocytic Leukemia/ Small ...

3. Study of Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer - Mayo Clinic

   Ki-67 index of ≥20% (for Cohort 2) on untreated breast tissue as determined by the investigational assay (described in Section 3.2.1) at the Study JPCF ...

4. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

   Cyanide-Nitroprusside Colorimetric Assay: A Rapid Colorimetric Screen for Urinary Cystine. J Appl Lab Med. 2017 Jul 1; 2 (1):55-64. View PubMed; Blackburn PR ...

5. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   ER/PR determination assays performed by IHC methods according to the local institution standard protocol; Standard chemotherapy/trastuzumab declined by ...

6. Team Bios - Gut Microbiome Laboratory - Mayo Clinic Research

   Singh studies the effects of gut microbes on adverse events associated with cancer treatments. She uses in vitro T-cell stimulation assay and gnotobiotic mouse ...

7. Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane with or without Chemotherapy in Treating Patients with Invasive RxPONDER Breast Cancer - Mayo Clinic

   ... Assay has not been performed, patients must be willing to submit tissue samples for testing to determine the Recurrence Score value; a representative block ...

8. A Trial of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR) - Mayo Clinic

   ... assays within 6 months prior to randomization. Key Exclusion Criteria: * Transplant: Blood type (ABO)-incompatible transplant. * History of multiple organ ...

9. A Registry Called Every Child for Collecting Data and Biology Specimens on Younger Patients with Cancer - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

    The primary objective of this study is to assess the effectiveness of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).